Literature DB >> 12788852

Association of I27L polymorphism of hepatocyte nuclear factor-1 alpha gene with high-density lipoprotein cholesterol level.

Naru Babaya1, Hiroshi Ikegami, Tomomi Fujisawa, Koji Nojima, Michiko Itoi-Babaya, Kaori Inoue, Jun Nakura, Michiko Abe, Miyuki Yamamoto, Jin Ji Jin, Zhihong Wu, Tetsuro Miki, Masakatsu Fukuda, Toshio Ogihara.   

Abstract

The serum level of high-density lipoprotein cholesterol (HDL-c), which protects against the development of atherosclerosis, is under genetic control. However, the genetic components responsible for the serum HDL-c level are yet to be determined. A recent knockout mouse study demonstrated that hepatocyte nuclear factor-1 alpha (HNF-1 alpha) is an essential transcriptional regulator of HDL-c metabolism. In this study, the association of an HNF-1 alpha gene polymorphism, isoleucine (Ile) 27 leucine (Leu), with lipid parameters, in particular with serum HDL-c level, was studied in 356 unrelated Japanese men. Though no significant difference was observed in total cholesterol and triglyceride levels among the three genotypes, the serum HDL-c level was significantly associated with the genotype (P < 0.01, trend test). Subjects with the Ile/Ile genotype had low serum HDL-c levels, and those with the Leu/Leu genotype had high serum HDL-c levels. These results demonstrate that the HNF-1 alpha gene locus is associated with serum HDL-c level and suggest that the Ile27 allele is a risk marker for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788852     DOI: 10.1210/jc.2002-021891

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure.

Authors:  Daxian Wu; Sainan Zhang; Zhongyang Xie; Ermei Chen; Qunfang Rao; Xiaoli Liu; Kaizhou Huang; Jing Yang; Lanlan Xiao; Feiyang Ji; Zhengyi Jiang; Yalei Zhao; Xiaoxi Ouyang; Danhua Zhu; Xiahong Dai; Zhouhua Hou; Bingjie Liu; Binbin Deng; Ning Zhou; Hainv Gao; Zeyu Sun; Lanjuan Li
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

2.  Identification and functional analysis of c.422_423InsT, a novel mutation of the HNF1A gene in a patient with diabetes.

Authors:  Jesús Miguel Magaña-Cerino; Juan P Luna-Arias; María Luisa Labra-Barrios; Bartolo Avendaño-Borromeo; Xavier Miguel Boldo-León; Mirian Carolina Martínez-López
Journal:  Mol Genet Genomic Med       Date:  2016-11-30       Impact factor: 2.183

3.  Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.

Authors:  Adrien Labriet; Elena De Mattia; Erika Cecchin; Éric Lévesque; Derek Jonker; Félix Couture; Angela Buonadonna; Mario D'Andrea; Lyne Villeneuve; Giuseppe Toffoli; Chantal Guillemette
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

4.  HNF1α defect influences post-prandial lipid regulation.

Authors:  Matthieu St-Jean; François Boudreau; André C Carpentier; Marie-France Hivert
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

5.  Association of the HNF1A polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke.

Authors:  Yi-Jiang Zhou; Rui-Xing Yin; Shao-Cai Hong; Qian Yang; Xiao-Li Cao; Wu-Xian Chen
Journal:  J Gene Med       Date:  2017-01       Impact factor: 4.565

Review 6.  HNF1A:From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.

Authors:  Li-Mei Li; Bei-Ge Jiang; Liang-Liang Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

Review 7.  Transcriptional control by HNF-1: Emerging evidence showing its role in lipid metabolism and lipid metabolism disorders.

Authors:  Fang Liu; Xiao Zhu; Xiaping Jiang; Shan Li; Yuncheng Lv
Journal:  Genes Dis       Date:  2021-07-19

8.  HNF1A gene polymorphisms and cardiovascular risk factors in individuals with late-onset autosomal dominant diabetes: a cross-sectional study.

Authors:  Fernando M A Giuffrida; Gilberto K Furuzawa; Teresa S Kasamatsu; Marcos M Oliveira; Andre F Reis; Sergio A Dib
Journal:  Cardiovasc Diabetol       Date:  2009-06-02       Impact factor: 9.951

Review 9.  Utility of genetic determinants of lipids and cardiovascular events in assessing risk.

Authors:  Michael V Holmes; Seamus Harrison; Philippa J Talmud; Aroon D Hingorani; Steve E Humphries
Journal:  Nat Rev Cardiol       Date:  2011-02-15       Impact factor: 32.419

10.  The Common HNF1A Variant I27L Is a Modifier of Age at Diabetes Diagnosis in Individuals With HNF1A-MODY.

Authors:  Jonathan M Locke; Cécile Saint-Martin; Thomas W Laver; Kashyap A Patel; Andrew R Wood; Seth A Sharp; Sian Ellard; Christine Bellanné-Chantelot; Andrew T Hattersley; Lorna W Harries; Michael N Weedon
Journal:  Diabetes       Date:  2018-06-12       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.